Flu vs COVID: Stark Disparity in Vaccination and Deaths
Despite safety and effectiveness, COVID vaccination rates remained lower than flu vaccination rates — and resulting death rates put this in a grim light.
Stay updated with breaking news from Cameronr Wolfe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Despite safety and effectiveness, COVID vaccination rates remained lower than flu vaccination rates — and resulting death rates put this in a grim light.
Pemgarda, a monoclonal antibody infusion therapy intended to protect people who are immunocompromised from COVID-19, has been authorized by the U.S. Food and Drug Administration. The prophylactic treatment is for people who may not develop sufficient resistance to COVID-19 after vaccination because they have medical conditions that weaken their immune system.
Invivyd Inc. announced on March 22 that its monoclonal antibody, Pemgarda, had received emergency use authorization from the US Food and Drug Administration.
The indication is for adults and adolescents with moderate to severe immune compromise due to medical conditions or immunosuppressive medications and treatments.
This change is effective May 11, when the federal Public Health Emergency ends, and is consistent with Duke’s peer universities, according to the email. Duke will continue to offer the primary and booster vaccinations free of charge to all students, faculty and staff.